These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16110817)

  • 1. Invasive aspergillosis in primary immunodeficiencies.
    Almyroudis NG; Holland SM; Segal BH
    Med Mycol; 2005 May; 43 Suppl 1():S247-59. PubMed ID: 16110817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive aspergillosis in chronic granulomatous disease.
    Segal BH; Romani LR
    Med Mycol; 2009; 47 Suppl 1():S282-90. PubMed ID: 19296367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
    Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
    J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NADPH oxidase in host defense against aspergillosis.
    Grimm MJ; Vethanayagam RR; Almyroudis NG; Lewandowski D; Rall N; Blackwell TS; Segal BH
    Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S144-9. PubMed ID: 20560866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction.
    Henriet SS; Verweij PE; Warris A
    J Infect Dis; 2012 Oct; 206(7):1128-37. PubMed ID: 22829648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infections in primary immunodeficiencies.
    Antachopoulos C; Walsh TJ; Roilides E
    Eur J Pediatr; 2007 Nov; 166(11):1099-117. PubMed ID: 17551753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood.
    Casale TB; Macher AM; Fauci AS
    South Med J; 1984 Feb; 77(2):274-5. PubMed ID: 6701605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
    Chang YC; Segal BH; Holland SM; Miller GF; Kwon-Chung KJ
    J Clin Invest; 1998 May; 101(9):1843-50. PubMed ID: 9576747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report.
    Kepenekli E; Soysal A; Kuzdan C; Ermerak NO; Yüksel M; Bakır M
    Ital J Pediatr; 2014 Jan; 40():2. PubMed ID: 24401677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus nidulans infection in chronic granulomatous disease.
    Segal BH; DeCarlo ES; Kwon-Chung KJ; Malech HL; Gallin JI; Holland SM
    Medicine (Baltimore); 1998 Sep; 77(5):345-54. PubMed ID: 9772923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary complications of primary immunodeficiencies.
    Buckley RH
    Paediatr Respir Rev; 2004; 5 Suppl A():S225-33. PubMed ID: 14980276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.
    Dotis J; Roilides E
    Int J Infect Dis; 2004 Mar; 8(2):103-10. PubMed ID: 14732328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.
    Henriet SS; Jans J; Simonetti E; Kwon-Chung KJ; Rijs AJ; Hermans PW; Holland SM; de Jonge MI; Warris A
    J Infect Dis; 2013 Jun; 207(12):1932-9. PubMed ID: 23482646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.
    Liu W; Yan M; Sugui JA; Li H; Xu C; Joo J; Kwon-Chung KJ; Coleman WG; Rodgers GP
    J Clin Invest; 2013 Sep; 123(9):3751-5. PubMed ID: 23908114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-gamma.
    Mamishi S; Zomorodian K; Saadat F; Gerami-Shoar M; Tarazooie B; Siadati SA
    Ann Clin Microbiol Antimicrob; 2005 Mar; 4():4. PubMed ID: 15745454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.
    Gallin JI; Zarember K
    Trans Am Clin Climatol Assoc; 2007; 118():175-85. PubMed ID: 18528501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
    Falcone EL; Holland SM
    Curr Opin Infect Dis; 2012 Dec; 25(6):658-69. PubMed ID: 22964947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus nidulans infection in a patient with chronic granulomatous disease.
    Kim M; Shin JH; Suh SP; Ryang DW; Park CS; Kim C; Kook H; Kim J
    J Korean Med Sci; 1997 Jun; 12(3):244-8. PubMed ID: 9250922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
    Romani L; Fallarino F; De Luca A; Montagnoli C; D'Angelo C; Zelante T; Vacca C; Bistoni F; Fioretti MC; Grohmann U; Segal BH; Puccetti P
    Nature; 2008 Jan; 451(7175):211-5. PubMed ID: 18185592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.